The Cooper Companies (COO) shares dropped 14% and were among the biggest decliners on the 澳洲幸运5官方开奖结果体彩网:S&P 500 Friday, a day after the contact lens maker lowered its full-year organic growth outlook.

The San Ramon, Calif.-based firm now sees fiscal 2025 organic growth of 5% to 6%, down from last quarter's forecast of 6% to 8% growth. However, Cooper raised its outlook for adjusted 澳洲幸运5官方开奖结果体彩网:earnings per share (EPS) to 🌄$4.05 to $﷽4.11 from the prior range of $3.94 to $4.02.

JPMorgan downgraded the stock to "neutral" from "overweight," and lowered its price target to $76 from $110, writing in a note that "it's hard to come away feeling positive following several quarters of mixed execution and a potentially durable slowdown in market trends back to previous levels." Wells Fargo also dropped its price target, to $93 from $118.

With today's sharp decline, Cooper shares have lost a quarter of their value this year.

Q2 Results Top Analysts' Estimates

Cooper reported fiscal second-quarter results that surpassed consensus estimates of analysts surveyed by Visible Alpha. The company posted adjꦓusted EPS of $0.96 on sales that rose 6% year-over-year to $1.00 billion, while analysts were calling for $0.93 and $994.1 million, respectively.

CooperVision revenue rose 5% to $669.6 million, while CooperSurgical revenue was up 8% to $332.7 million.